Capital Flow Monitor · Sponsors · CIK 1641241

Cyrus Biotechnology, Inc.

3005 1ST AVE, SEATTLE, WA, 98121 · 2062586561

Biotechnology · Corporation· inc. DELAWARE true

Fit score

—

Offering

$3.0M

Sold

$1.5M

% sold

49.4%

Investors

17

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-05-08 D/A ·current 506(b) $3.0M $1.5M 49.4% 17 EDGAR ↗
2025-07-16 D 506(b) $1.5M $1.1M 74.0% 12 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.